Schistosomiasis Control Initiative - Revision history

Vipul: /* Summary of who they are and what they do */

2013-02-19T07:48:06Z

Summary of who they are and what they do

← Older revision		Revision as of 07:48, 19 February 2013
Line 24:		Line 24:
	! Item !! Value		! Item !! Value
	\|-		\|-
	\| Countries of operation \|\| 8-10 African countries (~~which countries~~? ~~Difficult to glean~~)		\| Countries of operation \|\| 8-10 African countries: Uganda, Burkina Faso, Niger, Mali, Tanzania, Zambia, Rwanda, Burundi (any more?)
	\|-		\|-
	\| Headquarters \|\| Imperial College, London, United Kingdom		\| Headquarters \|\| Imperial College, London, United Kingdom

Vipul: /* History of operations and funding */

2013-02-19T07:36:23Z

History of operations and funding

← Older revision		Revision as of 07:36, 19 February 2013
Line 70:		Line 70:
	! Funder !! Year of funding !! Amount of funding !! Neglected Tropical Diseases (NTDs) tackled !! Countries tackled !! Expiry of grant !! Additional comments		! Funder !! Year of funding !! Amount of funding !! Neglected Tropical Diseases (NTDs) tackled !! Countries tackled !! Expiry of grant !! Additional comments
	\|-		\|-
	\| [[Gates Foundation]] (private philanthropic foundation that makes grants for developing world health charities) \|\| 2002 \|\| $32 million \|\| schistosomiasis, STHs \|\| six African countries: ~~{{fillin}}~~ \|\| unspecified \|\| This was a founding grant.		\| [[Gates Foundation]] (private philanthropic foundation that makes grants for developing world health charities) \|\| 2002 \|\| $32 million \|\| schistosomiasis, STHs \|\| six African countries: <toggledisplay>Uganda, Burkina Faso, Niger, Mali, Tanzania, Zambia</toggledisplay> \|\| unspecified \|\| This was a founding grant.
	\|-		\|-
	\| [[USAID]] (US federal grantmaking agency) and [[Gates Foundation]] \|\| 2006 \|\| ? \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma \|\| eight African countries~~: {{fillin}}~~ \|\| Till 2011 (five year grant) \|\|		\| [[USAID]] (US federal grantmaking agency) and [[Gates Foundation]] \|\| 2006 \|\| ? \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma \|\| eight African countries (or six? inconsistences between footnote and data) \|\| Till 2011 (five year grant) \|\|
	\|-		\|-
	\| ? \|\| 2007 \|\| ? \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma \|\| Rwanda and Burundi \|\| Till 2011 \|\| This was intended to expand the program from the eight current countries of operation to these two new countries.		\| ? \|\| 2007 \|\| ? \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma \|\| Rwanda and Burundi \|\| Till 2011 \|\| This was intended to expand the program from the eight current countries of operation to these two new countries.

Vipul: /* History of operations and funding */

2013-02-19T07:33:19Z

History of operations and funding

← Older revision		Revision as of 07:33, 19 February 2013
Line 78:		Line 78:
	\| [[DFID]] (UK central grantmaking agency) \|\| 2010 \|\| ? \|\| schistosomiasis, STHs \|\| eight African countries (same eight?) \|\| Till 2015 (?), five year grant \|\| Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>		\| [[DFID]] (UK central grantmaking agency) \|\| 2010 \|\| ? \|\| schistosomiasis, STHs \|\| eight African countries (same eight?) \|\| Till 2015 (?), five year grant \|\| Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>
	\|-		\|-
	! Total !! -- !! add up !! -- !! --		! Total !! -- !! add up !! -- !! -- !! -- !! --
	\|}		\|}

Vipul at 07:30, 19 February 2013

2013-02-19T07:30:11Z

← Older revision		Revision as of 07:30, 19 February 2013
Line 24:		Line 24:
	! Item !! Value		! Item !! Value
	\|-		\|-
	\| Countries of operation \|\| 8-10 African countries		\| Countries of operation \|\| 8-10 African countries (which countries? Difficult to glean)
	\|-		\|-
	\| Headquarters \|\| Imperial College, London, United Kingdom		\| Headquarters \|\| Imperial College, London, United Kingdom
Line 32:		Line 32:
	\| Method summary \|\| Advocate for the benefits of mass drug distributions to government officials.<br>Assist with planning and fund raising.<br>Deliver funding and drugs to governments.<br>Provide financial management and technical support.<br>Develop procedures for monitoring and evaluation.		\| Method summary \|\| Advocate for the benefits of mass drug distributions to government officials.<br>Assist with planning and fund raising.<br>Deliver funding and drugs to governments.<br>Provide financial management and technical support.<br>Develop procedures for monitoring and evaluation.
	\|-		\|-
	\| Previous sources of funding \|\| grant from [[Gates Foundation]] (private philanthropic foundation)<br>grants from [[USAID]] (US federal grantmaking agency)<br>grants from [[DFID]] (UK central grantmaking agency)		\| Previous sources of funding \|\| grant from [[Gates Foundation]] (private philanthropic foundation)<br>grants from [[USAID]] (US federal grantmaking agency)<br>grants from [[DFID]] (UK central grantmaking agency). More in the [[#History of operations and funding]] section.
	\|}		\|}

Line 50:		Line 50:

	==Operations and history==		==Operations and history==

	~~Note to GiveWell staff: ignore the red links, they are meant to be stand-ins for your current internal links to pages.~~

	{{quotation\|To understand this section better, follow the links to get more background information on these topics:<br>[[neglected tropical diseases]] (NTDs): diseases that currently afflict people largely in low-income tropical areas, particularly Africa, and are ''neglected'' by most research efforts in the developed world because they do not cause much trouble in developed world countries.<br>List of NTDs mentioned here: [[schistosomiasis]], [[soil-transmitted helminth]]s (acronym '''STH'''s), [[lymphatic filariasis]], [[onchocerciasis]], and [[trachoma]].<br>[[mass drug administration program]]: {{fillin}} }}		{{quotation\|To understand this section better, follow the links to get more background information on these topics:<br>[[neglected tropical diseases]] (NTDs): diseases that currently afflict people largely in low-income tropical areas, particularly Africa, and are ''neglected'' by most research efforts in the developed world because they do not cause much trouble in developed world countries.<br>List of NTDs mentioned here: [[schistosomiasis]], [[soil-transmitted helminth]]s (acronym '''STH'''s), [[lymphatic filariasis]], [[onchocerciasis]], and [[trachoma]].<br>[[mass drug administration program]]: {{fillin}} }}
Line 79:		Line 77:
	\|-		\|-
	\| [[DFID]] (UK central grantmaking agency) \|\| 2010 \|\| ? \|\| schistosomiasis, STHs \|\| eight African countries (same eight?) \|\| Till 2015 (?), five year grant \|\| Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>		\| [[DFID]] (UK central grantmaking agency) \|\| 2010 \|\| ? \|\| schistosomiasis, STHs \|\| eight African countries (same eight?) \|\| Till 2015 (?), five year grant \|\| Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>
			\|-
			! Total !! -- !! add up !! -- !! --
	\|}		\|}

Line 85:		Line 85:
	{{fillin}} -- long and tedious		{{fillin}} -- long and tedious

	===Overall spending ~~beakdown~~===		===Overall spending breakdown===

	{{fillin}} -- long and tedious		{{fillin}} -- long and tedious

Vipul at 23:43, 23 November 2011

2011-11-23T23:43:07Z

← Older revision		Revision as of 23:43, 23 November 2011
Line 80:		Line 80:
	\| [[DFID]] (UK central grantmaking agency) \|\| 2010 \|\| ? \|\| schistosomiasis, STHs \|\| eight African countries (same eight?) \|\| Till 2015 (?), five year grant \|\| Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>		\| [[DFID]] (UK central grantmaking agency) \|\| 2010 \|\| ? \|\| schistosomiasis, STHs \|\| eight African countries (same eight?) \|\| Till 2015 (?), five year grant \|\| Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>
	\|}		\|}

			===Other projects===

			{{fillin}} -- long and tedious

			===Overall spending beakdown===

			{{fillin}} -- long and tedious
			==Does it work?==

			===Independent evidence of program effectiveness===

			{{fillin}}

Vipul: /* Review process */

2011-11-23T23:22:58Z

Review process

← Older revision		Revision as of 23:22, 23 November 2011
Line 44:		Line 44:
	\| Effectiveness and other effects of these kinds of programs \|\| Study of the published literature		\| Effectiveness and other effects of these kinds of programs \|\| Study of the published literature
	\|-		\|-
	\| Details ~~of the~~ big picture of SCI's operations \|\| Extensive communications with SCI Director Alan Fenwick to discuss SCI's methods and funding needs<br>meetings with other staff at SCI's headquarters in London<br>Requesting and reviewing SCI internal financial and organizational documents.		\| Details and big picture of SCI's operations \|\| Extensive communications with SCI Director Alan Fenwick to discuss SCI's methods and funding needs<br>meetings with other staff at SCI's headquarters in London<br>Requesting and reviewing SCI internal financial and organizational documents.
	\|-		\|-
	\| Feel for how SCI's programs are run on the ground \|\| Visiting a national schistosomiasis control program meeting and demonstration mass drug administration in Malawi (site visit: October 2011)		\| Feel for how SCI's programs are run on the ground \|\| Visiting a national schistosomiasis control program meeting and demonstration mass drug administration in Malawi (site visit: October 2011)

Vipul: /* Summary of who they are and what they do */

2011-11-23T23:21:53Z

Summary of who they are and what they do

← Older revision		Revision as of 23:21, 23 November 2011
Line 24:		Line 24:
	! Item !! Value		! Item !! Value
	\|-		\|-
	\| Countries of operation \|\| ~~? (~~African countries)		\| Countries of operation \|\| 8-10 African countries
	\|-		\|-
	\| Headquarters \|\| Imperial College, London, United Kingdom		\| Headquarters \|\| Imperial College, London, United Kingdom

Vipul: /* History of operations and funding */

2011-11-23T23:14:18Z

History of operations and funding

← Older revision		Revision as of 23:14, 23 November 2011
Line 78:		Line 78:
	\| ? \|\| 2007 \|\| ? \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma \|\| Rwanda and Burundi \|\| Till 2011 \|\| This was intended to expand the program from the eight current countries of operation to these two new countries.		\| ? \|\| 2007 \|\| ? \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma \|\| Rwanda and Burundi \|\| Till 2011 \|\| This was intended to expand the program from the eight current countries of operation to these two new countries.
	\|-		\|-
	\| [[DFID]] (UK central grantmaking agency) \|\| 2010 \|\| ? \|\| schistosomiasis, STHs \|\| in eight countries (same eight?) \|\| Till 2015 (?), five year grant \|\| Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>		\| [[DFID]] (UK central grantmaking agency) \|\| 2010 \|\| ? \|\| schistosomiasis, STHs \|\| eight African countries (same eight?) \|\| Till 2015 (?), five year grant \|\| Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>
	\|}		\|}

Vipul: /* History of operations and funding */

2011-11-23T23:13:47Z

History of operations and funding

← Older revision		Revision as of 23:13, 23 November 2011
Line 74:		Line 74:
	\| [[Gates Foundation]] (private philanthropic foundation that makes grants for developing world health charities) \|\| 2002 \|\| $32 million \|\| schistosomiasis, STHs \|\| six African countries: {{fillin}} \|\| unspecified \|\| This was a founding grant.		\| [[Gates Foundation]] (private philanthropic foundation that makes grants for developing world health charities) \|\| 2002 \|\| $32 million \|\| schistosomiasis, STHs \|\| six African countries: {{fillin}} \|\| unspecified \|\| This was a founding grant.
	\|-		\|-
	\| [[USAID]] (US federal grantmaking agency) and [[Gates Foundation]] \|\| 2006 \|\| ~~unspecified~~ \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma \|\| eight African countries: {{fillin}} \|\| Till 2011 (five year grant) \|\|		\| [[USAID]] (US federal grantmaking agency) and [[Gates Foundation]] \|\| 2006 \|\| ? \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma \|\| eight African countries: {{fillin}} \|\| Till 2011 (five year grant) \|\|
	\|-		\|-
	\| ? \|\| 2007 \|\| ~~unspecified~~ \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma \|\| Rwanda and Burundi \|\| Till 2011 \|\| This was intended to expand the program from the eight current countries of operation to these two new countries.		\| ? \|\| 2007 \|\| ? \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma \|\| Rwanda and Burundi \|\| Till 2011 \|\| This was intended to expand the program from the eight current countries of operation to these two new countries.
	\|-		\|-
	\| [[DFID]] (UK central grantmaking agency) \|\| 2010 \|\| ~~unspecified~~ \|\| schistosomiasis, STHs \|\| in eight countries (same eight?) \|\| Till 2015 (?), five year grant \|\| Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>		\| [[DFID]] (UK central grantmaking agency) \|\| 2010 \|\| ? \|\| schistosomiasis, STHs \|\| in eight countries (same eight?) \|\| Till 2015 (?), five year grant \|\| Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>
	\|}		\|}

Vipul: /* Operations and history */

2011-11-23T23:13:07Z

Operations and history

← Older revision		Revision as of 23:13, 23 November 2011
Line 53:		Line 53:
	Note to GiveWell staff: ignore the red links, they are meant to be stand-ins for your current internal links to pages.		Note to GiveWell staff: ignore the red links, they are meant to be stand-ins for your current internal links to pages.

	{{quotation\|To understand this section better, follow the links to get more background information on these topics:<br>[[neglected tropical diseases]] (NTDs): diseases that currently afflict people largely in low-income tropical areas, particularly Africa, and are ''neglected'' by most research efforts in the developed world because they do not cause much trouble in developed world countries.<br>List of NTDs mentioned here: [[schistosomiasis]], [[soil-transmitted helminth]]s, [[lymphatic filariasis]], [[onchocerciasis]], and [[trachoma]].<br>[[mass drug administration program]]: {{fillin}} }}		{{quotation\|To understand this section better, follow the links to get more background information on these topics:<br>[[neglected tropical diseases]] (NTDs): diseases that currently afflict people largely in low-income tropical areas, particularly Africa, and are ''neglected'' by most research efforts in the developed world because they do not cause much trouble in developed world countries.<br>List of NTDs mentioned here: [[schistosomiasis]], [[soil-transmitted helminth]]s (acronym '''STH'''s), [[lymphatic filariasis]], [[onchocerciasis]], and [[trachoma]].<br>[[mass drug administration program]]: {{fillin}} }}

	===Broad description of goals and methods===		===Broad description of goals and methods===
Line 70:		Line 70:

	{\| class="sortable" border="1"		{\| class="sortable" border="1"
	! Funder !! Year of funding !! Amount of funding !! NTDs tackled !! Countries tackled !! Expiry of grant !! Additional comments		! Funder !! Year of funding !! Amount of funding !! Neglected Tropical Diseases (NTDs) tackled !! Countries tackled !! Expiry of grant !! Additional comments
	\|-		\|-
	\| [[Gates Foundation]] (private philanthropic foundation that makes grants for developing world health charities) \|\| 2002 \|\| $32 million \|\| schistosomiasis, STHs \|\| six African countries: {{fillin}} \|\| unspecified \|\| This was a founding grant.		\| [[Gates Foundation]] (private philanthropic foundation that makes grants for developing world health charities) \|\| 2002 \|\| $32 million \|\| schistosomiasis, STHs \|\| six African countries: {{fillin}} \|\| unspecified \|\| This was a founding grant.
	\|-		\|-
	\| [[USAID]] (US federal grantmaking agency) and [[Gates Foundation]] \|\| 2006 \|\| unspecified \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma, \|\| eight African countries: {{fillin}} \|\| Till 2011 (five year grant) \|\|		\| [[USAID]] (US federal grantmaking agency) and [[Gates Foundation]] \|\| 2006 \|\| unspecified \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma \|\| eight African countries: {{fillin}} \|\| Till 2011 (five year grant) \|\|
	\|-		\|-
	\| ? \|\| 2007 \|\| unspecified \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma, \|\| Rwanda and Burundi \|\| Till 2011 \|\| This was intended to expand the program from the eight current countries of operation to these two new countries.		\| ? \|\| 2007 \|\| unspecified \|\| schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma \|\| Rwanda and Burundi \|\| Till 2011 \|\| This was intended to expand the program from the eight current countries of operation to these two new countries.
	\|-		\|-
	\| [[DFID]] (UK central grantmaking agency) \|\| 2010 \|\| unspecified \|\| schistosomiasis, STHs \|\| in eight countries (same eight?) \|\| Till 2015 (?), five year grant \|\| Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>		\| [[DFID]] (UK central grantmaking agency) \|\| 2010 \|\| unspecified \|\| schistosomiasis, STHs \|\| in eight countries (same eight?) \|\| Till 2015 (?), five year grant \|\| Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>
	\|}		\|}